Imaging Biometrics Ltd. (FRA:5Y1)

Market Cap	1.35M -63.4%
Revenue (ttm)	816.46K -9.2%
Net Income	-166.18K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.0090
Previous Close	0.0090
Day's Range	0.0090 - 0.0090
52-Week Range	0.0005 - 0.0170
Beta	n/a
RSI	47.93
Earnings Date	May 1, 2026

About Imaging Biometrics

Imaging Biometrics Ltd., through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, Switzerland, European Union, and the United States. It operates through Holding Company, Medical Software, and Oral Gallium Maltolate (GaM) segments. The company develops ready-to-use software applications for the healthcare industry comprising IB Clinic for all IB software platforms; IB Neuro, a MR DSC perfusion processing platform; IB Delta Suite, which creates Delta T1 maps from routin...

• Industry: Prepackaged Software
• Founded: 1965
• Employees: 7
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5Y1

Financial Performance

In 2024, Imaging Biometrics's revenue was 750,105, an increase of 23.09% compared to the previous year's 609,390. Losses were -327,103, -47.56% less than in 2023.

Financial numbers in GBP